Company profile
Pasithea Therapeutics Corp.
NASDAQ:KTTABiotechnology: Pharmaceutical Preparations
Clinical trials (2)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT06961565 | phase1 | recruiting | 2025-05-30 | 2027-09-01 | Pasithea Therapeutics Corp. | PAS-004 in Adults Who Have Neurofibromatosis Type 1 With Plexiform Neurofibromas |
| NCT06299839 | phase1 | recruiting | 2024-02-29 | 2026-02-01 | Pasithea Therapeutics Corp. | PAS-004 in Patients With Advanced Solid Tumors |
FDA applications (0)
No records yet.